Company intelligence / Profile preview

Cato Corporation

Cary, North Carolina, United Statescatofashions.com ↗

Ownership: Private
Employees: ~1200
Development stage: Commercial

Overview

Allucent provides comprehensive clinical research and consulting services to small and mid-sized biopharmaceutical companies. The company has deep expertise in complex therapeutic areas such as oncology and rare diseases. It offers full-service clinical trial operations, biometrics services, regulatory strategy consulting, and more. The organization was formed through the merger of CATO SMS and Pharm-Olam in 2022 and subsequently rebranded as Allucent. It does not develop its own drugs but supports client programs across all development phases.

Therapeutic areas: OncologyImmunologyRare DiseasesNeurologyInfectious Diseases
Modalities: Small moleculeBiologicCell therapyGene therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on Cato Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cato Corporation.

Explore the full profile